Results 131 to 140 of about 1,054 (155)

Oral Rimegepant Safe, Effective for Migraine Prevention

JAMA, 2021
openaire   +2 more sources

New drug: rimegepant for migraine attacks

Ge-Bu, 2022
openaire   +1 more source

Efficacy of Rimegepant for the Acute Treatment of Migraine Based on Triptan Treatment Experience: Pooled Results From Three Phase 3 Randomized Clinical Trials

Cephalalgia, 2023
Richard B. Lipton, Beth Morris
exaly  

Nieuw geneesmiddel: rimegepant bij migraineaanvallen

Ge-Bu, 2022
openaire   +1 more source

Engineering a Transaminase for the Efficient Synthesis of a Key Intermediate for Rimegepant

Organic Process Research & Development, 2022
Yulei Ma, Xuecheng Jiao, Zujian Wang, Huiyan Mu, Kaihua Sun, Xiang Li, Tong Zhao, Xufeng Liu, Na Zhang   +8 more
openaire   +1 more source

Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine

Headache, 2020
Gary Berman, Richard B. Lipton, Robert Croop   +2 more
exaly  

Health State Utility Mapping of Rimegepant for the Preventive Treatment of Migraine: Double-Blind Treatment Phase and Open Label Extension (BHV3000-305)

Advances in Therapy, 2023
Richard B. Lipton, Karissa M. Johnston, Lauren C Powell   +2 more
exaly  

NICE recommends rimegepant for treating acute migraine in adults

BMJ, 2023
openaire   +2 more sources

Efficacy, Safety, and Tolerability of Rimegepant Orally Disintegrating Tablet for the Acute Treatment of Migraine: A Randomised, Phase 3, Double-Blind, Placebo-Controlled Trial

Lancet, The, 2019
Richard B. Lipton, David A Stock
exaly  

Rimegepant (Nurtec ODT)for Acute Treatment of Migraine

JAMA, 2020
openaire   +2 more sources